Literature DB >> 30394586

HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.

P M Russo1, E Fino1, C Mancini2, M Mazzetti1, M Starace1,2, B M Piraccini1,2.   

Abstract

BACKGROUND: Illness impact on HrQoL has been widely studied in hair loss-affected patients, yet no study has addressed whether individual differences modulate HrQoL in patients with alopecia areata (AA), androgenetic alopecia (AGA) and telogen effluvium (TE).
OBJECTIVE: To identify the personality dimensions most predictive of the impact of disease on HrQoL.
METHOD: A single-site cross-sectional study was carried out in the Dermatology Unit of Sant'Orsola-Malpighi Hospital, Bologna between September 2016 and September 2017. The study included 143 patients (105 females, ages 18-60 years) diagnosed with AA (n = 27), AGA (n = 80) and TE (n = 36). Illness severity, alopecia type, age, gender, education and civil status were documented. Health-related quality of life (HrQoL), personality traits, trait anxiety, emotional intelligence, social anxiety and social phobia were also measured.
RESULTS: AA, AGA and TE groups differed significantly for illness severity with most severe patients falling in AA type. For HrQoL, Gender × Group interaction resulted significant with AGA females reporting a higher impact of hair loss on quality of life than males, while TE males were more impacted by hair loss than AA and AGA males. Lower scores were obtained by AGA females than males on emotional intelligence while no significant differences were evidenced on other groups. A significant Gender × Group interaction was also found for trait anxiety, social phobia and social anxiety: consistently, AGA females reported higher scores than AGA males in all three measures. Finally, discriminant analysis evidenced that anxiety-related traits can contribute to reliably predict hair loss impact on HrQoL, regardless of illness severity and alopecia type.
CONCLUSIONS: We recommend that gender and individual differences in anxiety-related dimensions be considered as key factors in gaining a deeper understanding of hair loss impact on quality of life as well as in reducing the burden of illness in alopecia-affected patients.
© 2018 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2018        PMID: 30394586     DOI: 10.1111/jdv.15327

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  Evaluation of dry eye and Meibomian gland dysfunction in female androgenetic alopecia patients.

Authors:  Pelin Kiyat; Melis Palamar; Bengu Gerceker Turk; Ayse Yagci
Journal:  Int Ophthalmol       Date:  2021-07-09       Impact factor: 2.031

2.  Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.

Authors:  Atrin Toussi; Virginia R Barton; Stephanie T Le; Oma N Agbai; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2020-06-17       Impact factor: 15.487

3.  Association between Androgenetic Alopecia and Psychosocial Disease Burden: A Cross-Sectional Survey among Polish Men.

Authors:  Roksana Adamowicz; Piotr Załęcki; Anna Dukiel; Danuta Nowicka
Journal:  Dermatol Res Pract       Date:  2022-03-17

4.  Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels.

Authors:  Haifeng Wang; Lifang Pan; Yanfeng Wu
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

Review 5.  Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature.

Authors:  Santo Raffaele Mercuri; Giovanni Paolino; Matteo Riccardo Di Nicola; Laura Vollono
Journal:  Medicina (Kaunas)       Date:  2021-03-25       Impact factor: 2.430

Review 6.  Psychology's medicalization of male baldness.

Authors:  Glen S Jankowski; Hannah Frith
Journal:  J Health Psychol       Date:  2021-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.